Solas BioVentures — Full Portfolio

Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.

BiotechHealthtechHouston, US

David J. Tweardy(Executive Officer, Director)Josef Schoell(Executive Officer)inJoseph W. Stauffer(Executive Officer)Derek Chalmers(Executive Officer, Director)inMichael E. Lewis(Executive Officer)inFrederique Menzaghi(Executive Officer)

Co-investorsSHShangBay Capital LLC

Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.

BiotechDeep TechHealthtechMedical DevicesEdina, US

JKJay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJBJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAMAllen Meacham(President and Chief Executive Officer)inBSBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in

Co-investorsFRFresenius Medical Care Ventures

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System.

BiotechDigital HealthHealthtechMedical DevicesMaple Grove, US

MHMichael Hoey(Founder)inMichael Kujak(Executive Officer, Director)Christopher Dixon(Chief Medical Officer)in

BoardACAndrew Cleeland(Director)JGJan Garfinkle(Director)inDADavid Adair(Director)in

Board seatMHMichael Hoey· per SEC Form D

Co-investorsARArboretum Ventures

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation.

BiotechHealthtechMedical Devices

Paul J. Fitzpatrick(Chief Executive Officer)

Co-investorsCHChattanooga Renaissance FundINInnova Memphis, Inc.BLBlank Slate Ventures

Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsSCScientific Health Development

Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.

BiotechChapel Hill, US

RWRobin Walker(Executive Officer)inChristopher Courts(Executive Officer)inJorge Bartolome(Founder)in

BoardBenjamin Gomez(Director)AKAdam Koppel(Director)inMichael E. Bozik(Director)

Co-investorsARARCH Venture PartnersBABain Capital Life SciencesGVGV (Google Ventures)VIViking GlobalACAccess BiotechnologyMAMaverick Capital+3 more

Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.

BiotechMedical DevicesMorrisville, US

Karen Adams(Executive Officer)Stephen E. Butts(Executive Officer)

Co-investorsRERex Health VenturesOROrlando Health Ventures

Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients.

HardwareHealthtechMedical Devices

ELEric Leuthardt(Chief Executive Officer & Founder)inJGJenna Gorlewicz(Chief Technology Officer & Founder)inAHAnna Huguenard(Chief Medical Officer & Founder)inJWJesse Wheeler(Chief Operations Officer)inRKRyan Kight(Chief Financial Officer)in

Co-investorsDEDeep FutureKAKaleida Capital

Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training.

Digital HealthFemTechHealthtechMedical DevicesAuburndale, US

SPSamantha Pulliam(CEO and Chief Medical Officer)inVRVincent Ricci(Executive Officer)JOJim O'Connor(Executive Officer)inSPShacey Petrovic(Executive Officer, Director)inEileen Maus(Executive Officer, Director)in

BoardJonathan Dean(Director)

Co-investorsAVAvestria VenturesCACatalio Capital Management, LPCRCross-Border Impact Ventures

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

VPVamsee Pamula(Executive Officer, Director)in

BoardDennis Sacha(Director)William A. Hawkins(Director)

Co-investorsCHCharlotte Angel FundDUDuke Capital PartnersIAIAG Capital PartnersRERex Health VenturesVEVentureSouthHGHG Ventures+1 more

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.

BiotechDigital HealthHealthtechMedical DevicesCary, US

SNShahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)JOJulia Owens(Executive Officer, Director, Promoter)inRSRichard Shea(Executive Officer, Director, Promoter)in

BoardHannah Chang(Director)AAAiden Aceves(Director)in

Co-investorsARARCH Venture PartnersINInsight PartnersBRBroadview VenturesMEMedbluePLPlatanus VenturesRERev1 Ventures+1 more

CardioNXT develops cardiac mapping and navigation technology, including its iMap System, used to navigate next-generation pulsed field ablation (PFA) catheters for cardiac procedures such as pulmonary vein isolation and left atrium mapping.

HardwareHealthtechMedical DevicesWestminster, US

Donald Conty(Executive Officer, Director, Promoter)Jerome Edwards(Executive Officer, Director, Promoter)

BoardThomas Kurian(Director, Promoter)

Corcym is a medical device company that develops therapies and devices for patient care.

HardwareHealthtechMedical Devices

Co-investorsB B Capital

Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways.

BiotechHealthtechMedical DevicesArden Hills, US

LSLaura Stoltenberg(Executive Officer, Director)in

BoardDBDavid Belitz(Director)inDoug French(Director)James Eadie(Director)Donald Gonzales(Founder and Chief Medical Officer)

Co-investorsBRBrightstone Venture Capital

Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing.

BiotechHealthtechMedical DevicesNew MaterialsChicago, US

CNCaralynn Nowinski Collens(Co-founder & CEO)inRSRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Co-founder & CSO)AJAdam Jakus(Co-Founder)inLarry Weinstein(SVP, Manufacturing & Quality Operations)CJCole Johnson(SVP, Corporate Development)in

Co-investorsALAlumni VenturesBEBetter Ventures Central LlcHAHarvard Business Angels of ChicagoHAHAWKTAILLOLofty VenturesPAPathway Bioventures+4 more

EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings.

Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSChattanooga, US

RNRobert Newman(Executive Officer, Director, Promoter)inRyan Seaberg(Co-Founder)Tyler Seaberg(Executive Officer, Director, Promoter)

Co-investorsATAtlanta Technology AngelsCHChain Reaction

Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions.

Digital HealthHardwareMedical DevicesKnoxville, US

Ryan Wilemsen(Executive Officer)Stephen Grady Arnold(Executive Officer)Britton Alan Garrett(Executive Officer, Director)John Green(Executive Officer)Brent Laing(Executive Officer, Director)Brad Rouse(Director)

Co-investorsJUJumpstart Capital

Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms.

HardwareHealthtechMedical DevicesFridley, US

Harlan Lee Sorkin(Executive Officer, Director)Gil M. Vardi(Director)

BoardDenis Harrington(Director)inDADavid Adair(Director)inJim Bullock(Director)

Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes.

AI & Machine LearningDigital HealthHealthtechMedical DevicesOxford, US

Jeffrey June(Executive Officer, Director)Teresa June(Executive Officer)in

Co-investorsBRBroadview VenturesEAEarly Stage Partners, LP

Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.

BiotechHealthtech

Co-investorsLOLongitude CapitalPRProspect Venture PartnersRERex Health Ventures

Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022.

BiotechHealthtechPittsburgh, US

TVThomas V. Petzinger, Jr.(LLC Manager)MEMichael E. Bozik(LLC Manager)Steven Dworetzky(Executive Officer)

BoardBenjamin A. Gomez(LLC Manager)JSJeffrey S. McCormick(LLC Manager)inGregory T. Hebrank(LLC Manager)

Co-investorsSASaturn Partners

NX Prenatal is a molecular diagnostics company developing exosome-based liquid biopsy assays that detect adverse pregnancy conditions such as preterm birth, preeclampsia, and placenta accreta.

BiotechDigital HealthFemTechHealthtechLouisville, US

Paul Kortschak(Chief Executive Officer)GAIL PAGE(Executive Officer, Director)BRIAN BROHMAN(Executive Officer, Director)ROBERT SAUNDERS(Director)KEVIN BRAMER(Director)ALAN MACK(Director)

Co-investorsBEBelle Impact FundKEKeyhorse CapitalMIMindshift CapitalGOGolden SeedsPOPortfolia

Olympus develops medical technologies and solutions for detecting and treating disease.

HardwareHealthtechMedical Devices

Pathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries.

AI & Machine LearningHealthtechMedical Devices

Co-investorsCACANTILEVER INVESTORSINInnoventures IowaNENext Level VenturesLELevel Eight Ventures

Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.

AI & Machine LearningDigital HealthHealthtechPlymouth, US

Brian D. Athey(Co-founder)DJDaniel Jasewicz(Company Leadership (Strategy & Commercialization))inGHGerry Higgins(Scientific Strategy Lead)inAAAlex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)

PreTel develops wearable uterine electromyography sensors and AI-powered analysis software to monitor uterine contractions during pregnancy, enabling early detection of preterm labor, assessment of false labor, and guided Pitocin dosing during labor induction for obstetric care providers.

AI & Machine LearningFemTechMedical DevicesChattanooga, US

RYRoger Young(Chief Medical Officer / Founder)MFMarc Finch(CEO)

BoardMark A Samuels(Chairman)

Co-investorsTETech Square Ventures

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.

AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US

Chris Villongco(Head of Technology / CTO)inRKRob Krummen(CEO (formerly President & COO))inKPKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)

Co-investorsTVTVM CapitalTVTVM Capital Life Science

St.

HealthtechSt. Louis, US

SWScott Wrightstone(Executive Officer)inMaureen Oehler(Executive Officer)JPJason Pesterfield(Executive Officer, Director)inRDRyan Denney(Executive Officer)inMark Hunter(Executive Officer)inRobert Powers(Executive Officer)in

Co-investorsRCRC CapitalRERex Health VenturesADAdvantage Capital PartnersPRProlog VenturesVEVensana CapitalVEVersant Ventures

Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke.

Deep TechHealthtechMedical Devices

AJArthur J. Ulm(CTO/Founder/Board Member)